Equity Overview
Price & Market Data
Price: $0.105
Daily Change: -$0.003 / 2.86%
Range: $0.105 - $0.105
Market Cap: $13,257,514
Volume: 100
Performance Metrics
1 Week: 40.03%
1 Month: 24.62%
3 Months: -32.83%
6 Months: -11.55%
1 Year: -43.79%
YTD: 1.62%
Details
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey.